Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Biomerica Inc. BMRA

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

Recent & Breaking News (NDAQ:BMRA)

Biomerica's Aware® Breast Self Exam and EZ Detect(TM) Colon Disease Test Now Available on Amazon and Fulfilled by Amazon

GlobeNewswire 4 days ago

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

GlobeNewswire August 30, 2022

Biomerica Reports Fiscal 2022 Year End Results

GlobeNewswire August 29, 2022

Walmart to Begin Selling Biomerica's Aware® Breast Self Exam

GlobeNewswire July 14, 2022

Biomerica to Participate at BTIG Biotech Conference

GlobeNewswire June 23, 2022

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

Accesswire May 16, 2022

Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect(TM)

GlobeNewswire May 12, 2022

Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

GlobeNewswire April 26, 2022

Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021

GlobeNewswire April 14, 2022

Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome

GlobeNewswire February 8, 2022

Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021

GlobeNewswire January 13, 2022

Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million

GlobeNewswire December 16, 2021

Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening

GlobeNewswire November 19, 2021

Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment

GlobeNewswire November 4, 2021

Biomerica Launches New Website for Its Aware® Breast Exam Device

GlobeNewswire October 29, 2021

Walmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect(TM) Colorectal Screening Test

GlobeNewswire October 19, 2021

Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021

GlobeNewswire October 15, 2021

Walmart Now Selling Biomerica's EZ Detect(TM) Colorectal Screening Test

GlobeNewswire October 1, 2021

Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week

GlobeNewswire August 30, 2021

Biomerica Reports Fiscal 2021 Year End Results

GlobeNewswire August 27, 2021